Latest Health News from Duke Medicine News and Communications
David Zaas, M.D., Named President of Duke Raleigh Hospital
May 23, 2014
David W. Zaas, M.D., MBA, has been named president of Duke Raleigh Hospital, effective July 1, 2014.
One Molecule to Block Both Pain and Itch
May 22, 2014
Duke University researchers have found an antibody that simultaneously blocks the sensations of pain and itching in studies with mice.
Non-Invasive Lithotripsy Leads to More Treatment for Kidney Stones
May 16, 2014
When it comes to treating kidney stones, less invasive may not always be better, according to new research from Duke Medicine.
Duke University School of Nursing Announces Marion Broome as New Dean
May 13, 2014
Marion E. Broome, Ph.D., RN, FAAN, a nationally renowned leader in the nursing field, has been named dean of the Duke University School of Nursing. In addition, Broome will become associate vice president of academic affairs for nursing at Duke University Health System (DUHS).
ADHD Treatment Associated with Lower Smoking Rates
May 12, 2014
Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis led by researchers at Duke Medicine.
Bullying May Have Long-Term Health Consequences
May 12, 2014
Bullied children may experience chronic, systemic inflammation that persists into adulthood, while bullies may actually reap health benefits of increasing their social status through bullying, according to researchers at Duke Medicine.
Small Mutation Changes Brain Freeze to Hot Foot
May 8, 2014
Ice cream lovers and hot tea drinkers with sensitive teeth could one day have a reason to celebrate a new finding from Duke University researchers. The scientists have found a very small change in a single protein that turns a cold-sensitive receptor into one that senses heat.
Duke-led Team Clarifies Use of Anti-Fungal Drug for Premature Infants
May 3, 2014
In most circumstances, extremely premature babies should not be given a drug to prevent a potentially fatal fungal infection, according to findings by a Duke Medicine-led research team.
Duke Cancer Institute Teams with UNC, WUSTL to Speed Drug Development
May 2, 2014
A partnership formed by the Duke Cancer Institute, UNC Lineberger Comprehensive Cancer Center and the Siteman Cancer Center at Washington University in St. Louis will become part of a national network working to accelerate the pace of cancer drug development.
Statin Use Associated with Reduced Risk of Prostate Cancer Recurrence
May 1, 2014
Men who begin taking statins after prostate cancer surgery are less likely to have a recurrence of their cancer, according to a retrospective analysis led by researchers at Duke Medicine.